Please provide your email address to receive an email when new articles are posted on . In an analysis of data from two phase 3, multicenter studies of 1,217 adult patients randomized to the ...
Richard Adler, MD, FACS, leads a discussion on real-world signs, symptoms and patient reactions associated with the treatment for DED. This is a video synopsis/summary of a Post Conference ...
Please provide your email address to receive an email when new articles are posted on . DENVER – Treatment with the mitochondrial reactive oxygen species scavenger Visomitin resulted in reduced ...
HEIDELBERG, Germany & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology ...
Oculis is forging ahead with its precision medicine approach to treating dry eye disease, outlining plans to finalize a phase 3 study after seeing some signs of efficacy in a subpopulation in its ...
Ocular surface disease (OSD) is a prevalent yet frequently underrecognized challenge in the management of glaucoma. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results